IBM’s latest AI predicts Alzheimer’s better than standard tests

IBM has developed a new AI model which predicts the onset of Alzheimer’s better than standard clinical tests. The AI is designed to be non-invasive and uses a short language sample from a verbal cognitive test given to a patient. Using this sample, the AI model is able to predict the onset of Alzheimer’s with…

Read More

IBM uses AI to evaluate risk of developing genetic diseases

In a study published in the journal Nature Communications, scientists at IBM, the Broad Institute of MIT and Harvard, and health tech company Color find evidence the presence of genetic mutations isn’t a reliable precursor to genetic diseases. They claim diseases can so greatly be influenced by other factors that the risk in carriers is sometimes as low as that of noncarriers.

Read More